Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., F.C.P.S., MRCP-I (UK), Diploma in Aesthetic Medicine, Diploma in Invasive and Non Invasive Esthetics and Laser
Internal Medicine Specialist
M.B.B.S., F.C.P.S., MRCP-I (UK), Diploma in Aesthetic Medicine, Diploma in Invasive and Non Invasive Esthetics and Laser
Gastroenterologist
MBBS, Member of Royal College of Physicians (MRCP), (FCPS) Gastroenterology
Gastroenterologist
MBBS, Member of Royal College of Physicians (MRCP), (FCPS) Gastroenterology
Gastroenterologist
M.B.B.S, F.C.P.S. (Gastroenterology)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FACP (USA), FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Diabetologist
MBBS, Post Graduate Diploma In Diabetes (DIP)
Internal Medicine Specialist
M.B.B.S, F.C.P.S.(Medicine), M.R.C.P (Glasgow)
Internal Medicine Specialist
M.B.B.S, F.C.P.S.(Medicine), M.R.C.P (Glasgow)
Cardiologist
MBBS, MD(USA), FCPS (Cardiology), DipDiab
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures